FBLG (fibrobiologics.com) Market Value to Book Value Ratio

Official company branding of fibrobiologics.com (FBLG)

FibroBiologics, Inc. (FBLG) delegates drug production and testing to external contractors, leaving the company vulnerable to partner disruptions. Regulatory uncertainty and the high cost of research amid intense competition are weighing on shares, which are currently priced at 1.25. This trading chart visualizes the asset's price action. Growth prospects rely on retaining key developers through stock option programs.

FBLG fibrobiologics.com Market Cap to Book Value Multiple (02/21/2024 - 10/28/2026)

FBLG (FibroBiologics, Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price fibrobiologics.com|FBLG - Analyst Target Range
- market capitalization data:
Market Value FibroBiologics Corp|FBLG - Company Buyout Price
- book capitalization data:
Accounting Value per Share FibroBiologics|FBLG - Total Net Assets|Market Capitalization to Book Value Ratio fibrobiologics.com|FBLG - Company Assets
- debt and liquidity data:
Debt to Equity FibroBiologics, Inc.|FBLG - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital fibrobiologics.com|FBLG - Company Total Debt|Debts to Book Capitalization FibroBiologics Corp|FBLG - Long-Term Debt|Company Short-Term Debt FibroBiologics
Initial company analysis:FibroBiologics Inc.
Finished products of FibroBiologics, Inc.

FibroBiologics, Inc. (FBLG) operates in a pure R&D mode, sustaining itself through external financing and secondary offerings. This price-to-book ratio compares market capitalization to the size of total equity. The price-to-book ratio trend reflects a speculative premium over existing assets. An increase in this metric signals investor optimism regarding future discoveries, while a decrease demonstrates a devaluation of investments in the company's scientific potential.

Direct competitors

Market Capitalization to Book Value Ratio MESO (Mesoblast Limited)|LCTX (lineagecell.com) - Market Value to Equity Ratio|SRZN: Market Value to Book Value Ratio|Market Capitalization to Book Value Cryo-Cell International Inc (CCEL)|Market Cap to Net Assets Ratio Longeveron Corp|Market Cap to Book Value Multiple biorestorative.com (BRTX)|CELZ: Market Capitalization to Book Value Ratio